Research progress of pancreatic cancer venous thromboembolism
10.12092/j.issn.1009-2501.2021.10.011
- Author:
Xiaoling GONG
1
;
Haihui ZHOU
1
;
Yujie ZHOU
1
;
Xiaoling GONG
2
Author Information
1. China Pharmaceutical University, Nanjing Drum Tower Hospital
2. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
- Publication Type:Journal Article
- Keywords:
Pancreatic cancer;
Prevention and treatment;
Venous thromboembolism
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(10):1181-1185
- CountryChina
- Language:Chinese
-
Abstract:
The morbidity and mortality of pancreatic cancer are increasing year by year, and the risk of venous thromboembolism (VTE) in patients with pancreatic cancer is significantly increased, especially in the local advanced stage, metastatic stage and chemotherapy period. The patient's condition is often complicated by VTE events, which further increases the risk of death. This article reviews the latest literature, discusses the occurrence, development and clinical outcome of VTE in patients with pancreatic cancer, and introduces the research progress of pancreatic cancer VTE from the perspective of epidemiology, pathophysiology, clinical manifestations, prevention and treatment strategies.
